Search Results - "Patel, Tajhal"
-
1
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Published in Nature communications (28-06-2022)“…Neuroblastoma (NB) is a childhood cancer arising from sympatho-adrenal neural crest cells. MYCN amplification is found in half of high-risk NB patients;…”
Get full text
Journal Article -
2
Identification of an early survival prognostic gene signature for localized osteosarcoma patients
Published in Scientific reports (27-03-2024)“…Osteosarcoma is the most prevalent bone tumor in pediatric patients. Neoadjuvant chemotherapy has improved osteosarcoma patient survival, however the 5-year…”
Get full text
Journal Article -
3
LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination
Published in Oncogene (09-12-2022)“…Osteosarcoma, the most common pediatric bone tumor, is an aggressive heterogeneous malignancy defined by complex chromosomal aberrations. Overall survival…”
Get full text
Journal Article -
4
K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications
Published in Disease models & mechanisms (01-02-2022)“…Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, with overall long-term survival rates of ∼65-70%. Thus, additional molecular…”
Get full text
Journal Article -
5
p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma
Published in Oncogene (11-02-2021)“…Ewing sarcoma (ES) is the second most common bone tumor in children and young adults. Unfortunately, there have been minimal recent advancements in improving…”
Get full text
Journal Article -
6
MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma
Published in JCI insight (10-07-2023)“…Osteosarcoma (OS) is the most common primary bone tumor of childhood. Approximately 20%-30% of OSs carry amplification of chromosome 8q24, which harbors the…”
Get full text
Journal Article -
7
SOD1 is a synthetic-lethal target in PPM1D -mutant leukemia cells
Published in eLife (18-06-2024)“…The DNA damage response is critical for maintaining genome integrity and is commonly disrupted in the development of cancer. PPM1D (protein phosphatase Mg /Mn…”
Get full text
Journal Article -
8
Modeling Ewing Sarcoma Lung Metastasis
Published in Current protocols (01-02-2023)“…Ewing Sarcoma (EwS) is the second most common malignant bone tumor in adolescents and young adults. The single-most powerful predictor of outcome in EwS is…”
Get more information
Journal Article -
9
Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer
Published in Cancer medicine (Malden, MA) (01-01-2023)“…Background Non‐small cell lung cancer (NSCLC) comprises the majority (~85%) of all lung tumors, with lung adenocarcinoma (LUAD) and squamous cell carcinoma…”
Get full text
Journal Article -
10
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming
Published in Advanced science (01-10-2021)“…Neuroblastoma (NB) arises from oncogenic disruption of neural crest (NC) differentiation. Treatment with retinoic acid (RA) to induce differentiation has…”
Get full text
Journal Article -
11
Abstract 405: The role of GALNT14 in chemoresistant and metastatic osteosarcoma
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Introduction: Osteosarcoma is the most common bone tumor in children and adolescents. Many patients have disease progression through standard chemotherapy…”
Get full text
Journal Article -
12
Abstract 6147: Myc-driven osteosarcoma murine model for dissecting the molecular genetics and novel therapeutic strategies for OS
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Osteosarcoma (OS) is the most common bone tumor in pediatric patients, particularly in adolescents and young adults. Unfortunately, over the past four decades,…”
Get full text
Journal Article -
13
Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma
Published in Cancer research (Chicago, Ill.) (01-01-2021)“…Rhabdomyosarcoma (RMS) is the most prevalent pediatric soft-tissue sarcoma. Multimodal treatment, including surgery and traditional chemotherapy with…”
Get full text
Journal Article -
14
Abstract 6324: Development and characterization of Ewing Sarcoma lung metastasis model
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Introduction: Ewing Sarcoma (EwS) is the second most common bone tumor in children. At diagnosis, approximately 20-25% of patients with EwS have metastatic…”
Get full text
Journal Article -
15
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
Published in eLife (18-06-2024)“…The DNA damage response is critical for maintaining genome integrity and is commonly disrupted in the development of cancer. PPM1D (protein phosphatase Mg 2+…”
Get full text
Journal Article -
16
Abstract 1668: Development and characterization of a c-Myc-driven preclinical mouse model of osteosarcoma to investigate the tumor immune microenvironment
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Osteosarcoma (OS) is the most common bone tumor in pediatric patients, particularly in adolescents and young adults. Currently, no effective molecular targeted…”
Get full text
Journal Article -
17
Abstract 6713: Myc-regulated miR17, 20a modulate RANK expression in osteosarcoma
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. Approximately 25-30% of these tumors carry amplification of chromosome…”
Get full text
Journal Article -
18
Long non-coding RNAs regulation of therapeutic resistance
Published in Cancer drug resistance (01-01-2019)“…Non-protein coding RNAs have emerged as a regulator of cell signaling and cancer progression through regulation of cell proliferation, metastatic burden, and…”
Get full text
Journal Article -
19
Abstract 6047: Identification of a 13 gene signature to predict survival in localized osteosarcoma
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Osteosarcoma (OS) is the most prevalent bone tumor in pediatric patients. Regimens of neoadjuvant chemotherapy have improved survival of OS patients greatly,…”
Get full text
Journal Article